The adoption of the accountable care organization (ACO) model is changing the way hospitals evaluate their structure, roles, activities and benchmarks. While much of the buzz is about the IT tools and investments ACOs are driving to support population health management and collaborative care, business process change is the biggest challenge facing healthcare providers today. For medical device companies, sales and pricing models must adjust to address decision making by committees and risk sharing models in pricing for solutions. Device companies need to determine how their products add value in a world driven by data and analytics, with the goal of providing a holistic view of the patient.
"What was once a payment is now a cost. What was once a cost is now a potential savings. Is this a revolution, or evolution with an accelerated adoption curve?" asked Frost & Sullivan Vice President of Healthcare and Life Sciences Greg Caressi, during the opening of his speech at the 18th Annual Medical Devices 2013: A Frost & Sullivan Executive MindXchange. Caressi continued: "Successful approaches must reduce fragmentation to align with the future. Are you part of the problem or part of the solution?"
For a copy of his presentation, Healthcare 2025: Personalization Without PCP, or more information on The 19th Annual Medical Devices 2014: A Frost & Sullivan Executive MindXchange, please email Britni Myers, Corporate Communications, at email@example.com, with your full name, company name, job title, telephone number, company email address, company website, city, state and country.